TY - JOUR
T1 - The scenario approach for countries considering the addition of oral cholera vaccination in cholera preparedness and control plans
AU - Deen, Jacqueline
AU - von Seidlein, Lorenz
AU - Luquero, Francisco J.
AU - Troeger, Christopher
AU - Reyburn, Rita
AU - Lopez, Anna Lena
AU - Debes, Amanda
AU - Sack, David A.
N1 - Funding Information:
Our work was supported by the Delivering Oral Vaccine Effectively (DOVE) project, which is funded by the Bill & Melinda Gates Foundation and administered through the Johns Hopkins Bloomberg School of Public Health.
Publisher Copyright:
© 2016 Elsevier Ltd
PY - 2016/1
Y1 - 2016/1
N2 - Oral cholera vaccination could be deployed in a diverse range of situations from cholera-endemic areas and locations of humanitarian crises, but no clear consensus exists. The supply of licensed, WHO-prequalified cholera vaccines is not sufficient to meet endemic and epidemic needs worldwide and so prioritisation is needed. We have developed a scenario approach to systematically classify situations in which oral cholera vaccination might be useful. Our scenario approach distinguishes between five types of cholera epidemiology based on experiences from around the world and provides evidence that we hope will spur the development of detailed guidelines on how and where oral cholera vaccines could, and should, be most rationally deployed.
AB - Oral cholera vaccination could be deployed in a diverse range of situations from cholera-endemic areas and locations of humanitarian crises, but no clear consensus exists. The supply of licensed, WHO-prequalified cholera vaccines is not sufficient to meet endemic and epidemic needs worldwide and so prioritisation is needed. We have developed a scenario approach to systematically classify situations in which oral cholera vaccination might be useful. Our scenario approach distinguishes between five types of cholera epidemiology based on experiences from around the world and provides evidence that we hope will spur the development of detailed guidelines on how and where oral cholera vaccines could, and should, be most rationally deployed.
UR - http://www.scopus.com/inward/record.url?scp=85027921703&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85027921703&partnerID=8YFLogxK
U2 - 10.1016/S1473-3099(15)00298-4
DO - 10.1016/S1473-3099(15)00298-4
M3 - Review article
C2 - 26494426
AN - SCOPUS:85027921703
SN - 1473-3099
VL - 16
SP - 125
EP - 129
JO - The Lancet Infectious Diseases
JF - The Lancet Infectious Diseases
IS - 1
ER -